Form4insider filings, from the source

SEC Form 4 · accession 0000904454-15-000286

aTYR PHARMA INC · LIFE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jesse I Treu
10% Owner
James C Blair
Director · 10% Owner
Brian H Dovey
10% Owner
Brian K Halak
10% Owner
Period of report
May 12, 2015
Accepted (ET)
May 12, 2015 · 9:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F4,F5,F6,F7May 12, 2015C1,807,820—A1,807,820D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series C Preferred StockF2,F4,F5,F6,F1—May 12, 2015C12,143,933D——Common Stock1,526,7450D
Series D Preferred StockF2,F4,F5,F6,F1—May 12, 2015C1,506,901D——Common Stock189,4490D
Series E Preferred StockF3,F4,F5,F6,F1—May 12, 2015C887,073D——Common Stock91,6260D

Explanation of responses